The 21st century is the era of life science and it has made possible the analysing and harnessing of the innate potential of living organisms for the purpose of developing more advanced medical therapies and medicines.
We at PhoenixBio wish to play our part in this development by focusing our efforts on the research and application of the immense intrinsic potential of the human cell and the preservation of this potential outside the human body. We have succeeded in developing technologies for mass propagation of human cells and in transplanting these propagated cells into laboratory animals, enabling us to provide business services that make possible the wide and easy application of the vast potential the human cell has to offer.
|Company Name||PhoenixBio Co., Ltd.|
|Capital||2,245million yen (Mar. 2018)|
|3-4-1, Kagamiyama, Higashi-Hiroshima City
|PhoenixBio USA Corporation:
Overseas Marketing and Sales
|65 Broadway, Suite 605, New York
NY, 10006 USA
|KMT Hepatech Inc.||2011-94 Street NW,Edmonton, Alberta,Canada T6N 1H1|